Converge Bio

Converge Bio offers biotechnology with its GenAI platform to accelerate drug discovery and development. Leveraging Large Language Models (LLMs) trained in biological languages empowers biotech and pharmaceutical companies. It predicts molecule functionality, designs vaccines, discovers drug targets, and engineers novel proteins with precision. The platform’s curated data, fine-tuned models, and robust application layer streamline processes like antibody generation and biomarker identification, transforming complex challenges into actionable insights.